Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-14

Clinical Trial Update: Channa Striatus Extract on Albumin and Hs-CRP ESRD [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating Channa Striatus extract on albumin and hs-CRP in end-stage renal disease with inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Channa Striatus extract

Snippet

Sponsor: Universitas Sebelas Maret | Conditions: End-Stage Renal Disease, Inflammation | Phase 4 | Status: COMPLETED